483 Glenmark Pharmaceuticals Sep 2013

483 Glenmark Pharmaceuticals Sep 2013

Scott Laufenberg FDA$119.00 - Available Now

FDA investigators audited the Glenmark Pharmaceuticals - Bardez, India facility and issued inspectional observations (via FDA 483) on 25 Sep 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 25 Sep 2013
  • Location: Bardez, India
  • FEI: 3004672766
Add To Cart